Improved detection of advanced oxidation protein products in plasma

Clinica Chimica Acta

Volumn 413, Issue 9-10, 2012, Pages 901-906

  Hanasand, Marita ^a   Omdal, Roald ^a,b   Norheim, Katrine B ^a   Gøransson, Lasse G ^a,b   Brede, Cato ^a   Jonsson, Grete ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Advanced oxidation protein products; Chronic inflammation; Lipoprotein solubility; Method validation; Protein oxidation; Spectrophotometry

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; CITRIC ACID;

ACCURACY; ADULT; ARTICLE; CASE REPORT; CHRONIC KIDNEY DISEASE; FEMALE; HUMAN; LIGHT SCATTERING; LIPID SOLUBILITY; MALE; OXIDATIVE STRESS; PRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; REPRODUCIBILITY; SJOEGREN SYNDROME; SPECTROPHOTOMETRY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PROTEINS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; OXIDATIVE STRESS; REPRODUCIBILITY OF RESULTS; SJOGREN'S SYNDROME; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84858621301     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.01.038     Document Type: Article

References (38)

1. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997, 82:291-295.
2. Hancock J.T., Desikan R., Neill S.J. Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans 2001, 29:345-350.
3. Babior B.M. NADPH oxidase: an update. Blood 1999, 93:1464-1476.
4. Dean R.T., Fu S.L., Stocker R., Davies M.J. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997, 324:1-18.
5. West A.P., Brodsky I.E., Rahner C., et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011, 472:476-480.
6. Halliwell B., Gutteridge J.M., Cross C.E. Free radicals, antioxidants, and human disease: where are we now?. J Lab Clin Med 1992, 119:598-620.
7. Aruoma O.I. Free radicals, oxidative stress, and antioxidants in human health and disease. J Am Oil Chem Soc 1998, 75:199-212.
8. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006, 52:601-623.
9. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997, 272:20313-20316.
10. Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev 2000, 32:307-326.
11. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003, 329:23-38.
12. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996, 49:1304-1313.
13. Witko-Sarsat V., Nguyen-Khoa T., Jungers P., Drueke T.B., Descamps-Latscha B. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant 1999, 14(Suppl. 1):76-78.
14. Heinecke J.W., Li W., Daehnke H.L., Goldstein J.A. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem 1993, 268:4069-4077.
15. Capeillere-Blandin C., Gausson V., Descamps-Latscha B., Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 2004, 1689:91-102.
16. Selmeci L., Szekely M., Soos P., et al. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels. Free Radic Res 2006, 40:952-958.
17. Lozovoy M.A., Simao A.N., Panis C., et al. Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erithematosus. Lupus 2011, 20:1250-1259.
18. Baskol G., Demir H., Baskol M., et al. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem Funct 2006, 24:307-311.
19. Avinash S.S., Anitha M., Vinodchandran, Rao G.M., Sudha K., Shetty B.V. Advanced oxidation protein products and total antioxidant activity in colorectal carcinoma. Indian J Physiol Pharmacol 2009, 53:370-374.
20. Barsotti A., Fabbi P., Fedele M., et al. Role of advanced oxidation protein products and thiol ratio in patients with acute coronary syndromes. Clin Biochem 2011, 44:605-611.
21. Valli A., Suliman M.E., Meert N., et al. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors. Clin Chim Acta 2007, 379:87-94.
22. Kroll M.H. Evaluating interference caused by lipemia. Clin Chem 2004, 50:1968-1969.
23. Anderstam B., Bragfors-Helin A.C., Valli A., Stenvinkel P., Lindholm B., Suliman M.E. Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. Clin Chim Acta 2008, 393:114-118.
24. Capeillere-Blandin C., Gausson V., Nguyen A.T., Descamps-Latscha B., Drueke T., Witko-Sarsat V. Respective role of uraemic toxins and myeloperoxidase in the uraemic state. Nephrol Dial Transplant 2006, 21:1555-1563.
25. Witko V., Nguyen A.T., Descamps-Latscha B. Microtiter plate assay for phagocyte-derived taurine-chloramines. J Clin Lab Anal 1992, 6:47-53.
26. Kimura M., Murayama K., Nomoto M. Colorimetric detection of peptides with tert.-butyl hypochlorite and potassium iodide. J Chromatogr 1969, 41:458-461.
27. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
28. Matoltsy A.G., Matoltsy M.N. The chemical nature of keratohyalin granules of the epidermis. J Cell Biol 1970, 47:593-603.
29. Klavons J.A., Bennett R.D. The nature of the protein constituent of commercial lemon juice cloud. J Agric Food Chem 1985, 33:708-712.
30. Zhang Y., Cremer P.S. Interactions between macromolecules and ions: the Hofmeister series. Curr Opin Chem Biol 2006, 10:658-663.
31. Sun H., Li H., Sadler P.J. Transferrin as a metal ion mediator. Chem Rev 1999, 99:2817-2842.
32. Kaneda H., Taguchi J., Ogasawara K., Aizawa T., Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002, 162:221-225.
33. Mezzano D., Pais E.O., Aranda E., et al. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 2001, 60:1844-1850.
34. Codoner-Franch P., Tavarez-Alonso S., Murria-Estal R., Tortajada-Girbes M., Simo-Jorda R., Alonso-Iglesias E. Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children. Nutr Metab Cardiovasc Dis 2010, 12:1841-1846.
35. Matteucci E., Biasci E., Giampietro O. Advanced oxidation protein products in plasma: stability during storage and correlation with other clinical characteristics. Acta Diabetol 2001, 38:187-189.
36. Cunningham L.W., Nuenke B.J. Physical and chemical studies of a limited reaction of iodine with proteins. J Biol Chem 1959, 234:1447-1451.
37. Perlman G.E., Kaufman D. The effect of acetic acid on the stability of serum proteins. J Biol Chem 1949, 179:133-137.
38. Vicca S., Massy Z.A., Hennequin C., et al. New insights into the effects of the protein moiety of oxidized LDL (oxLDL). Kidney Int Suppl 2003, 84:S125-S127.